Pricing Log in Create free account

Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Telomir Pharmaceuticals, Inc. (TELO)

Corbus Pharmaceuticals Holdings, Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($57.5M and $55.3M). Across the 9 metrics below, Telomir Pharmaceuticals, Inc. leads on 5 and Corbus Pharmaceuticals Holdings, Inc. on 4.

Valuation

Metric CRBP TELO Biotechnology median
P/E n/m n/m 10.26
P/S 36.05 n/m 9.18
P/B 0.54 9.43 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.37 n/m 0.65
EV/Sales (26.17) n/m 8.98
Earnings yield (216.43%) (116.67%) (34.89%)
Free cash flow yield (156.18%) (10.36%) (24.52%)

Profitability

Metric CRBP TELO Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (95.58%) (1,885.50%) (50.12%)
Return on assets (80.85%) (1,678.31%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBP TELO Biotechnology median
Revenue growth (TTM) (73.69%) — 6.26%
EPS growth (last fiscal year) (60.33%) 41.07% 29.88%
Revenue growth, 5-year CAGR (14.34%) — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CRBP TELO Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 5.71 16.14 4.89
Net debt to EBITDA 1.90 0.69 1.01

Dividend

Metric CRBP TELO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBP TELO Biotechnology median
Market cap 55.32m 57.48m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack